Singapore markets open in 5 hours 37 minutes
Straits Times Index
3,322.08 -8.69 (-0.26%) S&P 500
5,362.40 +15.41 (+0.29%) Dow
38,845.11 +46.12 (+0.12%) Nasdaq
17,204.72 +71.60 (+0.42%) Bitcoin USD
69,622.35 -173.84 (-0.25%) CMC Crypto 200
1,445.97 -0.70 (-0.05%)
LLY Jan 2026 490.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:57PM EDT. Market open.
| Previous close | 12.50 |
| Open | 11.75 |
| Bid | 9.20 |
| Ask | 12.15 |
| Strike | 490.00 |
| Expiry date | 2026-01-16 |
| Day's range | 11.75 - 12.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 37 |
Yahoo FinanceEli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes with ongoing criticism about pricing and access.
ZacksBiogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
FDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of Alzheimer's drug Leqembi. The final FDA decision is expected on Jan 25, 2025.
ZacksEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
© 2024 Yahoo. All rights reserved.